A Double-Blind, Multicentre Comparison of Intravenous Dolasetron Mesilate and Metoclopramide in the Prevention of Nausea and Vomiting in Cancer Patients Receiving High-Dose Cisplatin Chemotherapy
Supportive Care in Cancer - Germany
doi 10.1007/bf01681958
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 1997
Authors
Publisher
Springer Science and Business Media LLC